SUNPHARMABSESun Pharmaceutical Industries LtdMediumNeutral
Announced Thu, 14 May · 12:25 IST

Intimation for receipt of request for reclassification of shareholders category

Promoter Stake Sell 1pctPromoter Below 50pctOwnership Changes View source PDF

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.0%1-day move
₹1823.60
prior close
₹1859.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.2+0.2+0.4+3.0+4.4+3.4+3.1+3.5+1.1-2.2-1.1+6.6
Up moveDown movePending
AI summary

Sun Pharma has received requests from three members of the Promoter Group — Mr. Sudhir Vrundavandas Valia, Mrs. Raksha Sudhir Valia, and Mrs. Krishna Vrundavandas Valia — seeking reclassification of their status from 'Promoter Group' to 'Public' category. The combined holding involved is 4,31,75,371 shares, representing 1.80% of total share capital. Mr. Valia holds 1,43,45,019 shares (0.60%) and Mrs. Raksha Valia holds 2,88,30,352 shares (1.20%), while Mrs. Krishna Valia's holding details are not provided. The company will examine these requests and place them before the Board for consideration, subject to which an application will be submitted to the stock exchanges.

Likely market impact

Reduction in the listed promoter group's shareholding by up to 1.80%, signalling potential dilution of promoter control. This reclassification will shift shares from the promoter category to the public float, which may impact the company's promoter holding percentage below the 50% mark.